Hormonal changes in patients undergoing therapeutic abortion with prostaglandin F2alpha, 15(S)-15-methyl-prostaglandin F2alpha and hypertonic saline.
D000019:Abortifacient Agents / Q000627:therapeutic use*; D000032:Abortion, Therapeutic; D000653:Amniotic Fluid; D002404:Catheterization; D004958:Estradiol / Q000097:blood*; D005260:Female; D006801:Humans; D010928:Placental Lactogen / Q000097:blood*; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011262:Pregnancy Trimester, Second; D011374:Progesterone / Q000097:blood*; D011453:Prostaglandins / Q000008:administration & dosage / Q000627:therapeutic use*; D012965:Sodium Chloride / Q000008:administration & dosage / Q000627:therapeutic use; D014599:Uterus
D000019:Abortifacient Agents; D011453:Prostaglandins; D012965:Sodium Chloride; D011374:Progesterone; D004958:Estradiol; D010928:Placental Lactogen